194 related articles for article (PubMed ID: 24008003)
21. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
Liuni A; Luca MC; Gori T; Parker JD
J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516
[TBL] [Abstract][Full Text] [Related]
22. Premature atherosclerosis in systemic sclerosis patients: Its relation to disease parameters and to traditional risk factors.
Sedky Abdou MM; El Desouky SM; Helmy El Kaffas KM; Ahmed Hassan AM
Int J Rheum Dis; 2017 Mar; 20(3):383-389. PubMed ID: 28036158
[TBL] [Abstract][Full Text] [Related]
23. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
24. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
[TBL] [Abstract][Full Text] [Related]
25. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM
Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
[TBL] [Abstract][Full Text] [Related]
26. Statin therapy improves brachial artery endothelial function in nephrotic syndrome.
Dogra GK; Watts GF; Herrmann S; Thomas MA; Irish AB
Kidney Int; 2002 Aug; 62(2):550-7. PubMed ID: 12110017
[TBL] [Abstract][Full Text] [Related]
27. Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.
Lind L; Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
J Am Soc Echocardiogr; 2012 Oct; 25(10):1120-1127.e1. PubMed ID: 22884641
[TBL] [Abstract][Full Text] [Related]
28. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein lowering with rosuvastatin in the METEOR study.
Peters SA; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Raichlen JS; Bots ML
J Intern Med; 2010 Aug; 268(2):155-61. PubMed ID: 20412373
[TBL] [Abstract][Full Text] [Related]
30. Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.
Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
J Atheroscler Thromb; 2011; 18(11):1018-28. PubMed ID: 21921413
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of rosuvastatin in the management of dyslipidemia.
Rubba P; Marotta G; Gentile M
Vasc Health Risk Manag; 2009; 5(1):343-52. PubMed ID: 19436657
[TBL] [Abstract][Full Text] [Related]
32. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
Moura LM; Ramos SF; Zamorano JL; Barros IM; Azevedo LF; Rocha-Gonçalves F; Rajamannan NM
J Am Coll Cardiol; 2007 Feb; 49(5):554-61. PubMed ID: 17276178
[TBL] [Abstract][Full Text] [Related]
33. Difference in statin effects on neointimal coverage after implantation of drug-eluting stents.
Yamamoto H; Ikuta S; Kobuke K; Yasuda M; Ikeda T; Yamaji K; Ueno M; Iwanaga Y; Miyazaki S
Coron Artery Dis; 2014 Jun; 25(4):290-5. PubMed ID: 24614628
[TBL] [Abstract][Full Text] [Related]
34. A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.
Hall AS; Jackson BM; Farrin AJ; Efthymiou M; Barth JH; Copeland J; Bailey KM; Romaine SP; Balmforth AJ; McCormack T; Whitehead A; Flather MD; Nixon J;
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):712-21. PubMed ID: 19745745
[TBL] [Abstract][Full Text] [Related]
35. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
[TBL] [Abstract][Full Text] [Related]
36. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.
Domsic RT; Dezfulian C; Shoushtari A; Ivanco D; Kenny E; Kwoh CK; Medsger TA; Champion HC
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-154-60. PubMed ID: 25372799
[TBL] [Abstract][Full Text] [Related]
37. Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
Ott C; Schlaich MP; Schmidt BM; Titze SI; Schäufele T; Schmieder RE
Atherosclerosis; 2008 Feb; 196(2):704-11. PubMed ID: 17298834
[TBL] [Abstract][Full Text] [Related]
38. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia.
Igase M; Kohara K; Tabara Y; Nagai T; Ochi N; Kido T; Ochi M; Miki T
Menopause; 2012 Dec; 19(12):1294-9. PubMed ID: 22850442
[TBL] [Abstract][Full Text] [Related]
39. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
Hamilton SJ; Chew GT; Davis TM; Watts GF
Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560
[TBL] [Abstract][Full Text] [Related]
40. Rosuvastatin improves pulse wave reflection by restoring endothelial function.
Ott C; Schneider MP; Schlaich MP; Schmieder RE
Microvasc Res; 2012 Jul; 84(1):60-4. PubMed ID: 22484031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
